Kyoto–Tokyo consortium launches first-of-its-kind zirconia recycling project for dental waste

Under the new initiative, each company takes on a defined role across the recycling chain

Gandhar Oil posts robust FY26 profit

PAT soars 201%, EBITDA up 88% on strong PHPO demand & margin expansion

Morepen Labs posts strong Q4 FY26 net profit

For the full year, standalone gross revenue crossed Rs. 1,700 crore

Quotient Sciences advances AI-designed drug product into Phase I clinical study

Company launches clinical study of AI-designed oral formulation following MHRA approval, marking a major milestone in AI-driven drug development.

Jubilant Ingrevia delivers 14-quarter high revenue in Q4 FY26 as margins strengthen across biz

The company highlighted continued demand strength and pricing resilience despite global disruptions

Novo Nordisk study exposes “hidden” inflammation driving cardio risk despite care

POSEIDON is among the largest global datasets to quantify this residual inflammatory burden

Tecan launches direct India operations

The move signals a major expansion milestone for the Swiss laboratory automation company

Siegfried locks in CHF 200m bond deal as investors bet big on pharma outsourcing boom

The bonds, due June 15, 2030, were placed with Swiss investors under the joint lead of UBS and Zürcher Kantonalbank

Eli lilly goes all-in on vaccines with $3b+ triple acquisition push into infectious disease prevention

Lilly will acquire Curevo in a deal worth up to $1.5 billion in cash, including upfront and milestone-based payments.

Fredun FY26 profit jumps 60% as revenue hits Rs. 639 Cr

International Nurses Day 2026: WHO highlights global nursing gaps despite workforce growth

Fresh data from the State of the World’s Nursing 2025 report shows the global nursing workforce has expanded from 27.9 million in 2018 to 29.8 million in 2023

EMA backs conditional EU nod for Vijoice in rare life-threatening overgrowth disorder PROS

The company is expected to conduct further studies to confirm the long-term efficacy and safety of Vijoice in both adult and paediatric patients

Oral GLP-1 race heats up as Lilly’s Foundayo shines in seniors

The company said all doses achieved statistically significant reductions in body weight compared with placebo at 72 weeks

AbbVie scores key EU backing for Hepatitis C drug in push for earlier treatment

If cleared, MAVIRET would become one of the few therapies in the European Union approved to treat both acute and chronic hepatitis C infections

Anupam Rasayan to acquire 43.3%–48.2% equity stake in Bliss GVS Pharma

The acquisition marks Anupam Rasayan’s strategic entry into the pharmaceutical formulations segment

SMS Pharma posts 48% profit surge in FY26 as margins expand & portfolio shift drives growth

Revenue from operations climbed 13% to Rs. 886.87 crore

EMA accepts filing for Teva and Medincell’s long-acting schizophrenia treatment candidate

If approved, TEV-‘749 would mark a shift toward long-acting care aimed at improving treatment adherence in real-world settings

ZIM Laboratories wins European regulatory milestone with anticoagulant approval in Italy

The approval was granted by Agenzia Italiana del Farmaco

Gujarat Themis Biosyn acquires MicroBiopharm Japan for Rs. 1,300 Cr

Transition to a fermentation-based globally integrated CDMO platform

OncoSil secures TGA approval for pancreatic cancer device

Approval of device in Australia for treating locally advanced pancreatic cancer alongside gemcitabine-based chemotherapy